Results 1 to 10 of about 1,460 (116)

Hantavirus Cardiopulmonary Syndrome and Diffuse Alveolar Hemorrhage in the Era of COVID-19. [PDF]

Case Rep Infect Dis, 2021
Hantavirus Cardiopulmonary Syndrome (HCPS) can occur after infection with Hantavirus which can occur by inhaling aerosolized rodent urine, feces, and saliva contaminated with the virus.
Hamid K, Sathyanarayanan SP, Naim T, Hamza M, Mahmood Baig MO, Sitta EA.   +5 more
europepmc   +3 more sources

Targeted high volume hemofiltration could avoid extracorporeal membrane oxygenation in some patients with severe Hantavirus cardiopulmonary syndrome. [PDF]

J Med Virol, 2021
Abstract Background Hantavirus cardiopulmonary syndrome (HCPS) has a high lethality. Severe cases may be rescued by venoarterial extracorporeal membrane oxygenation (VA ECMO), alongside substantial complications. High volume hemofiltration (HVHF) is a depurative technique that provides homeostatic balance allowing hemodynamic stabilization in some ...
López R, Pérez-Araos R, Salazar Á, Espinoza M, Vial C, Cuiza A, Vial PA, Graf J.   +7 more
europepmc   +3 more sources

Hantavirus Cardiopulmonary syndrome: Another Reason to Avoid Mice. [PDF]

J Investig Med High Impact Case Rep
Hantavirus cardiopulmonary syndrome is a severe illness transmitted by rodent excretions. We describe a case of a 24-year-old man who presented to the emergency department with cough, shortness of breath, chills, myalgias, nausea, and diarrhea.
Kennedy M, Mctabi O, Rickman C.
europepmc   +3 more sources

Platelet Count in Patients with Mild Disease at Admission is Associated with Progression to Severe Hantavirus Cardiopulmonary Syndrome. [PDF]

Viruses, 2019
Background: Hantavirus cardiopulmonary syndrome (HCPS) has a mortality up to 35–40% and its treatment is mainly supportive. A variable to predict progression from mild to severe disease is unavailable. This study was performed in patients with documented
López R, Vial C, Graf J, Calvo M, Ferrés M, Mertz G, Cuiza A, Agüero B, Aguilera D, Araya D, Pailamilla I, Paratori F, Torres-Torres V, Vial PA, Hantavirus Study Group in Chile.   +14 more
europepmc   +4 more sources

Hantavirus Cardiopulmonary Syndrome in Canada. [PDF]

Emerg Infect Dis, 2020
Hantavirus cardiopulmonary syndrome (HCPS) is a severe respiratory disease caused by Sin Nombre virus in North America (SNV). As of January 1, 2020, SNV has caused 143 laboratory-confirmed cases of HCPS in Canada.
Warner BM, Dowhanik S, Audet J, Grolla A, Dick D, Strong JE, Kobasa D, Lindsay LR, Kobinger G, Feldmann H, Artsob H, Drebot MA, Safronetz D.   +12 more
europepmc   +2 more sources

Bayou Hantavirus Cardiopulmonary Syndrome, Louisiana, USA, 2022-2023. [PDF]

Emerg Infect Dis
During 2020–2023, we sequenced Bayou virus from 2 patients in Louisiana, USA, with hantavirus cardiopulmonary syndrome. Direct virus sequencing demonstrated an inferred evolutionary relationship to previous cases.
Ortega E, Simonson S, Shedroff E, Whitmer S, Whitesell A, Choi MJ, Shoemaker T, Montgomery JM, Klena JD, Hennig J, Sokol T.   +10 more
europepmc   +2 more sources

Two Atypical Cases of Hantavirus Infection: Experience from a Tertiary Care Unit in Sri Lanka

Case Reports in Infectious Diseases, 2021
Hantaviruses are a large family of enveloped viruses with two medically important families Cricetidae and Muridae which are known to cause rodent-borne diseases worldwide.
S. Rupasinghe, S. Bowattage, L. Herath, A. Rajaratnam   +3 more
doaj   +2 more sources

Plasma Exchange for Hantavirus Pulmonary Syndrome: A Mechanistic Case for an Untested Intervention. [PDF]

J Clin Apher
ABSTRACT Hantavirus pulmonary syndrome (HPS) carries a case fatality rate of 35%–40% and has no approved pharmacologic treatment. Its pathophysiology is rooted in the plasma compartment: cytokines, viral antigens, immune complexes, and platelet‐binding glycoproteins circulate as drivers of immunopathologic endothelial injury, noncardiogenic pulmonary ...
Nadim M, Mirzabeigi Y, Akgun Y.
europepmc   +2 more sources

The Changing Landscape of Hantavirus Infections: A Narrative Review of Epidemiology, Pathogenesis, and Countermeasures. [PDF]

Rev Med Virol
ABSTRACT Hantaviruses are emerging zoonotic pathogens of increasing global public health significance. Their epidemiological landscape is rapidly changing due to ecological disruption, climate variability, urbanisation, and evolving human–animal interfaces.
De Maria F, Branda F, Ceccarelli G, Scarpa F, Ciccozzi M, Russo A.   +5 more
europepmc   +2 more sources

A Nonfatal Case of Dobrava Hantavirus Hemorrhagic Fever with Renal Syndrome Combined with Hantavirus Cardiopulmonary Syndrome. [PDF]

J Glob Infect Dis, 2018
Among hantaviruses (HTNV), 22 are known as pathogenic for humans. HTNV can cause two clinical entities: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome or hantavirus cardiopulmonary syndrome (HCPS).
Dreshaj S, Ajazaj L, Hasani N, Halili B, Ponosheci A, Jakupi X.   +5 more
europepmc   +2 more sources